📰 Human Use News
Page 82 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
March 31, 2023
Recommendation for approval based on Phase 3 TRANSFORM study, supporting the potential of Breyanzi in earlier lines of therapy in this patient population ... | March 31, 2023
March 31, 2023
~ First Therapy Recommended for Approval in the European Union for Reducing the Risk of Cisplatin-induced Hearing Loss in Pediatric Patients with Localized, Non-metastatic Solid Tumors~ ~ Positive... | March 31, 2023
March 31, 2023
If subsequently approved, Entresto will be the first and only approved therapy for the treatment of symptomatic chronic heart failure patients aged 1 to Pediatric heart failure is an important cause
March 31, 2023
The European Medicines Agency said on Friday its committee has recommended expanding the use of Danish drugmaker Novo Nordisk's weight loss drug in adolescents aged 12 years and older.
March 31, 2023
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of lisocabtagene maraleucel for the treatment of select patients with large B-cell lymphoma who relapsed within 12 months from completion of or developed refractory disease to frontline chemoimmunotherapy.
March 30, 2023
EQS-News: PAION AG / Key word: Annual Results PAION AG reports on fiscal year 2022 30.03.2023 / 07:30 CET/CEST The issuer is solely responsible for the content of this... | March 30, 2023
March 30, 2023
EQS-News: PAION AG / Key word(s): Annual Results PAION AG reports on fiscal year 2022 30.03.2023 / 07:30 CET/CEST The issue...
March 30, 2023
EQS-News: PAION AG / Key word(s): Annual ResultsPAION AG reports on fiscal year 2022 30.03.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement. PAION AG reports on fiscal year 2022 Combined revenues of EUR 33.2 million Cash and cash equivalents of EUR 10.6 million as of 3...
March 29, 2023
Debt investment, FVOCI - equity investment or FVTPL. Financial assets are not reclassified subsequent to their initial recognition unless the Company changes its business model for... | March 29, 2023
March 29, 2023
Caution Concerning Forward-Looking Statements The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated... | March 29, 2023